Thyroid hormone replacement therapy in dialysis/renal insufficiency patients may improve cardiac function while also posing a number of potential risks, such as nervousness, palpitations, atrial fibrillation, and worsening angina pector-is (51). This evidence concerns the gene TG and Renal insufficiency.